NEW YORK--(BUSINESS WIRE)--Western Asset High Income Opportunity Fund Inc. (NYSE: HIO) today announced the financial position of the Fund as of December 31, 2024. NAVs are calculated as of the close ...
As of December 31, 2025, GenSight Biologics' cash and cash equivalents totaled €2.4 million, up from €0.6 million as of September 30. This increase reflects the partial funds from the €2.9 million ...